Archives: Publications
Multicystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy
Eran Nizri, Dario Baratti, Marcello Guaglio, Snita Sinukumar, Antonello Cabras,Shigeki Kusamura, Marcello Deraco
Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma
H. Richard Alexander, Jr, MD, David L. Bartlett, MD, James F. Pingpank, MD, Steven K. Libutti, MD, Richard Royal, MD, Marybeth S. Hughes, MD, Matthew Holtzman, MD, Nader Hanna, MD, Keli Turner, MD, Tatiana Beresneva, MD, and Yue Zhu, MD, MS
Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study
Dario Baratti, MD, Shigeki Kusamura, PhD, Antonello Domenico Cabras, MD, and Marcello Deraco, MD
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma
Aaron U. Blackham, M.D. and Edward A. Levine, M.D.
Cytoreductive Surgery and Hyperthermic IntraperitonealChemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan, Marcello Deraco, Dario Baratti, Shigeki Kusamura, Dominique Elias, Olivier Glehen, Francois N. Gilly, Edward A. Levine, Perry Shen, Faheez Mohamed, Brendan J. Moran, David L. Morris,Terence C. Chua, Pompiliu Piso, and Paul H. Sugarbaker
Consensus Statement on Peritoneal Mesothelioma
MARCELLO DERACO,MD, DAVID BARTLETT, SHIGEKI KUSAMURA,MD, AND DARIO BARATTI,MD
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal SurfaceMalignancies Oncoteam—S.I.C.O.'
Luigi Marano, MD, PhD, Daniele Marrelli, MD, Paolo Sammartino, MD, PhD, Daniele Biacchi, MD, PhD,Luigina Graziosi, MD, PhD, Elisabetta Marino, MD, Federico Coccolini, MD, Paola Fugazzola, MD, Mario Valle, MD, Orietta Federici, MD, Dario Baratti, MD, Marcello Deraco, MD, Andrea Di Giorgio, MD, Antonio Macrì, MD, Enrico Maria Pasqual, MD, Massimo Framarini, MD, PhD, Marco Vaira, MD, Franco Roviello, MD
A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology
Brian Badgwell, MD, MS, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Xuemei Wang, MS,Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Prajnan Das, MD, Bruce D. Minsky, MD,Elizabeth Lano, MD, Shumei Song, PhD, Paul Mansfield, MD, and Jaffer Ajani, MD
Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao*, Min Yan and Zheng-Gang Zhu
Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of therandomized controlled trials
Yan-Wen Liu, Ying Du and Bao-An Chen